Alterations in cell metabolism, including changes in lipid composition occurring during malignancy, are well characterized for various tumor types. However, a significant part of studies that deal with brain tumors have been performed using cell cultures and animal models. Here, we present a dataset of 124 high-resolution negative ionization mode lipid profiles of human brain tumors resected during neurosurgery. The dataset is supplemented with 38 non-tumor pathological brain tissue samples resected during elective surgery. The change in lipid composition alterations of brain tumors enables the possibility of discriminating between malignant and healthy tissues with the implementation of ambient mass spectrometry. On the other hand, the col...
<p>Average negative-mode DESI spectra (<i>m/z</i> 700–1000) for (A) grey matter, n = 223; (B) white ...
Imaging mass spectrometry (IMS) represents an innovative tool in the cancer research pipeline, which...
© 2019 American Association for Cancer Research. Glioblastoma (GBM) is increasingly recognized as a ...
Glioblastoma (GBM) is the most common and malignant form of human primary brain tumor. Due to its ex...
Glioblastoma (GBM) is the most common and malignant form of human primary brain tumor. Due to its ex...
Desorption electrospray ionization-mass spectrometry (DESI-MS) imaging was used to analyze unmodifie...
Glioblastoma multiforme (GBM) is the most common and malignant form of primary brain tumors. It is h...
The main goal of brain tumor surgery is to maximize tumor resection while preserving brain function....
<div><p>Desorption electrospray ionization—mass spectrometry (DESI-MS) imaging was used to analyze u...
<p>(A) Representative positive ionization mode ion images of specimen 51 and (B) representative nega...
Desorption electrospray ionization—mass spectrometry (DESI-MS) imaging was used to analyze unmodifie...
The development of a fast and accurate intraoperative method that enables the differentiation and st...
Glioblastoma Multiforme (GBM) is the most common and malignant form of the primary brain tumor. Due ...
Examination of tissue sections using desorption electrospray ionization (DESI)-MS revealed phospholi...
Glioblastoma (GBM) is increasingly recognized as a disease involving dysfunctional cellular metaboli...
<p>Average negative-mode DESI spectra (<i>m/z</i> 700–1000) for (A) grey matter, n = 223; (B) white ...
Imaging mass spectrometry (IMS) represents an innovative tool in the cancer research pipeline, which...
© 2019 American Association for Cancer Research. Glioblastoma (GBM) is increasingly recognized as a ...
Glioblastoma (GBM) is the most common and malignant form of human primary brain tumor. Due to its ex...
Glioblastoma (GBM) is the most common and malignant form of human primary brain tumor. Due to its ex...
Desorption electrospray ionization-mass spectrometry (DESI-MS) imaging was used to analyze unmodifie...
Glioblastoma multiforme (GBM) is the most common and malignant form of primary brain tumors. It is h...
The main goal of brain tumor surgery is to maximize tumor resection while preserving brain function....
<div><p>Desorption electrospray ionization—mass spectrometry (DESI-MS) imaging was used to analyze u...
<p>(A) Representative positive ionization mode ion images of specimen 51 and (B) representative nega...
Desorption electrospray ionization—mass spectrometry (DESI-MS) imaging was used to analyze unmodifie...
The development of a fast and accurate intraoperative method that enables the differentiation and st...
Glioblastoma Multiforme (GBM) is the most common and malignant form of the primary brain tumor. Due ...
Examination of tissue sections using desorption electrospray ionization (DESI)-MS revealed phospholi...
Glioblastoma (GBM) is increasingly recognized as a disease involving dysfunctional cellular metaboli...
<p>Average negative-mode DESI spectra (<i>m/z</i> 700–1000) for (A) grey matter, n = 223; (B) white ...
Imaging mass spectrometry (IMS) represents an innovative tool in the cancer research pipeline, which...
© 2019 American Association for Cancer Research. Glioblastoma (GBM) is increasingly recognized as a ...